Evolus (EOLS) News Today $13.99 -0.63 (-4.31%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$13.89 -0.10 (-0.71%) As of 02/21/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Evolus to Participate in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness SummitFebruary 20 at 10:41 AM | finance.yahoo.comRice Hall James & Associates LLC Has $10.47 Million Stake in Evolus, Inc. (NASDAQ:EOLS)Rice Hall James & Associates LLC boosted its stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 4.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 948,281 shares of the company's stocFebruary 18, 2025 | marketbeat.comEvolus's SWOT analysis: FDA nod for filler boosts stock outlookFebruary 17, 2025 | msn.comEvolus' (EOLS) "Buy" Rating Reiterated at HC WainwrightFebruary 17, 2025 | americanbankingnews.comHC Wainwright Reiterates "Buy" Rating for Evolus (NASDAQ:EOLS)HC Wainwright restated a "buy" rating and set a $27.00 price target on shares of Evolus in a report on Friday.February 15, 2025 | marketbeat.comEvolus (NASDAQ:EOLS) Stock Price Up 15.3% - What's Next?Evolus (NASDAQ:EOLS) Stock Price Up 15.3% - Here's WhyFebruary 14, 2025 | marketbeat.comLegato Capital Management LLC Sells 43,769 Shares of Evolus, Inc. (NASDAQ:EOLS)Legato Capital Management LLC lessened its position in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 40.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 64,778 shares of the company's stock after selling 43,769 shares duringFebruary 14, 2025 | marketbeat.comEvolus Gets FDA Approval for Two Injectable Hyaluronic Acid GelsFebruary 13, 2025 | marketwatch.comEvolus trading halted, news pendingFebruary 13, 2025 | markets.businessinsider.comEvolus announces FDA approval of Evolysse productsFebruary 13, 2025 | markets.businessinsider.comEvolus Announces FDA Approval of Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid GelsFebruary 13, 2025 | finance.yahoo.comEvolus Announces FDA Approval of Evolysseâ„¢ Form and Evolysseâ„¢ Smooth Injectable Hyaluronic Acid GelsFebruary 13, 2025 | businesswire.comUS FDA approves Evolus' anti-wrinkle gelsFebruary 13, 2025 | reuters.comEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 7, 2025 | businesswire.comEvolus (NASDAQ:EOLS) Shares Down 6.5% - Should You Sell?Evolus (NASDAQ:EOLS) Shares Down 6.5% - Here's WhyFebruary 3, 2025 | marketbeat.comBarclays Sticks to Their Buy Rating for Evolus (EOLS)January 27, 2025 | markets.businessinsider.comEvolus price target raised to $22 from $20 at BarclaysJanuary 27, 2025 | markets.businessinsider.comEvolus (NASDAQ:EOLS) Given New $22.00 Price Target at BarclaysBarclays lifted their price objective on shares of Evolus from $20.00 to $22.00 and gave the stock an "overweight" rating in a report on Monday.January 27, 2025 | marketbeat.comHC Wainwright Issues Positive Estimate for Evolus EarningsEvolus, Inc. (NASDAQ:EOLS - Free Report) - HC Wainwright upped their Q4 2024 EPS estimates for shares of Evolus in a research note issued on Wednesday, January 22nd. HC Wainwright analyst D. Tsao now expects that the company will earn $0.00 per share for the quarter, up from their prior estimateJanuary 24, 2025 | marketbeat.comEvolus’s Strong Market Position and Growth Prospects Lead to Buy RatingJanuary 23, 2025 | markets.businessinsider.comHC Wainwright Predicts Evolus' FY2029 Earnings (NASDAQ:EOLS)Evolus, Inc. (NASDAQ:EOLS - Free Report) - Equities research analysts at HC Wainwright issued their FY2029 earnings estimates for shares of Evolus in a research note issued on Wednesday, January 22nd. HC Wainwright analyst D. Tsao forecasts that the company will post earnings per share of $4.43 fJanuary 23, 2025 | marketbeat.comEvolus’s Strong Growth and Market Expansion Justify Buy RatingJanuary 23, 2025 | markets.businessinsider.comMizuho Securities Reaffirms Their Buy Rating on Evolus (EOLS)January 23, 2025 | markets.businessinsider.comEvolus (NASDAQ:EOLS) Given Buy Rating at HC WainwrightHC Wainwright reissued a "buy" rating and set a $27.00 price objective on shares of Evolus in a report on Wednesday.January 22, 2025 | marketbeat.comStifel maintains Buy on Evolus, price target steady at $25January 21, 2025 | msn.comEvolus (NASDAQ:EOLS) Given "Buy" Rating at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and issued a $22.00 target price on shares of Evolus in a report on Tuesday.January 21, 2025 | marketbeat.comEvolus (NASDAQ:EOLS) Shares Gap Up - Time to Buy?Evolus (NASDAQ:EOLS) Shares Gap Up - Should You Buy?January 21, 2025 | marketbeat.comEvolus Shares Rise on Jump in RevenueJanuary 21, 2025 | marketwatch.comEvolus projects robust 2025 growth with upcoming product launchesJanuary 21, 2025 | msn.comEvolus Q4 Preliminary Revenue Improves, Expects Revenue Growth In 2025; Pre-Market Stock Up Over 16%January 21, 2025 | markets.businessinsider.comEvolus shares surge on strong Q4 results and upbeat 2025 outlookJanuary 21, 2025 | msn.comAssenagon Asset Management S.A. Lowers Holdings in Evolus, Inc. (NASDAQ:EOLS)Assenagon Asset Management S.A. lessened its stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 54.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 435,453 shares of the company's stock after selling 52January 21, 2025 | marketbeat.comJPMorgan Chase & Co. Buys 65,972 Shares of Evolus, Inc. (NASDAQ:EOLS)JPMorgan Chase & Co. boosted its stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 63.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 169,926 shares of the company's stock after purchasing an additional 65,972 shares duJanuary 21, 2025 | marketbeat.comEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 17, 2025 | businesswire.comEvolus: Still Bullish, But Business Faces Tricky Challenges In '25January 14, 2025 | seekingalpha.comEvolus (NASDAQ:EOLS) Reaches New 12-Month Low - Should You Sell?Evolus (NASDAQ:EOLS) Hits New 1-Year Low - What's Next?January 14, 2025 | marketbeat.comBarclays PLC Acquires 68,213 Shares of Evolus, Inc. (NASDAQ:EOLS)Barclays PLC increased its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 268.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 93,662 shares of the company's stock after buying an additional 68January 13, 2025 | marketbeat.comEvolus (NASDAQ:EOLS) Sets New 52-Week Low - Here's What HappenedEvolus (NASDAQ:EOLS) Sets New 1-Year Low - Time to Sell?January 8, 2025 | marketbeat.comBarclays PLC Has $1.52 Million Stake in Evolus, Inc. (NASDAQ:EOLS)Barclays PLC grew its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 268.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 93,662 shares of the company's stock after purchasing an additional 68,213 shareDecember 29, 2024 | marketbeat.comInsider Selling: Evolus, Inc. (NASDAQ:EOLS) CFO Sells 1,586 Shares of StockDecember 27, 2024 | insidertrades.comEvolus, Inc. (NASDAQ:EOLS) CFO Sells $17,208.10 in StockEvolus, Inc. (NASDAQ:EOLS - Get Free Report) CFO Sandra Beaver sold 1,586 shares of the firm's stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $10.85, for a total transaction of $17,208.10. Following the transaction, the chief financial officer now directly owns 146,916 shares in the company, valued at $1,594,038.60. The trade was a 1.07 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.December 26, 2024 | marketbeat.comEvolus, Inc. (NASDAQ:EOLS) Insider Sells $24,434.20 in StockEvolus, Inc. (NASDAQ:EOLS - Get Free Report) insider Rui Avelar sold 2,252 shares of the company's stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $10.85, for a total transaction of $24,434.20. Following the completion of the sale, the insider now directly owns 366,595 shares of the company's stock, valued at approximately $3,977,555.75. This represents a 0.61 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.December 26, 2024 | marketbeat.comEvolus, Inc. (NASDAQ:EOLS) Shares Sold by State Street CorpState Street Corp reduced its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 4.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,277,841 shares of the company's stock afterDecember 24, 2024 | marketbeat.comLord Abbett & CO. LLC Buys 188,685 Shares of Evolus, Inc. (NASDAQ:EOLS)Lord Abbett & CO. LLC raised its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 23.4% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 995,449 shares of the company's stock after purchasing an additional 188,68December 16, 2024 | marketbeat.comEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 13, 2024 | businesswire.comCharles Schwab Investment Management Inc. Raises Stake in Evolus, Inc. (NASDAQ:EOLS)Charles Schwab Investment Management Inc. boosted its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 173.7% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 418,576 shares of the company's stock after acquiringDecember 12, 2024 | marketbeat.comWalleye Capital LLC Invests $3.44 Million in Evolus, Inc. (NASDAQ:EOLS)Walleye Capital LLC bought a new stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 212,209 shares of the company's stock, valued at approximately $3,43December 3, 2024 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Buys New Stake in Evolus, Inc. (NASDAQ:EOLS)Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 58,046 shares of the company's stock, valued at approximately $940,000November 28, 2024 | marketbeat.comEvolus, Inc. (NASDAQ:EOLS) Stake Decreased by Great Point Partners LLCGreat Point Partners LLC reduced its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 52.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 1,170,000 shares of the company's stock after selling 1,281,772 shares during the period. Evolus makes upNovember 27, 2024 | marketbeat.comEvolus (NASDAQ:EOLS) Trading Down 3.8% - Here's What HappenedEvolus (NASDAQ:EOLS) Trading Down 3.8% - Here's WhyNovember 22, 2024 | marketbeat.com Get Evolus News Delivered to You Automatically Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter. Email Address EOLS Media Mentions By Week EOLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EOLS News Sentiment▼0.800.60▲Average Medical News Sentiment EOLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EOLS Articles This Week▼54▲EOLS Articles Average Week Get Evolus News Delivered to You Automatically Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Arcellx News Today Akero Therapeutics News Today Rhythm Pharmaceuticals News Today Scholar Rock News Today Immunovant News Today Apellis Pharmaceuticals News Today Viking Therapeutics News Today ACADIA Pharmaceuticals News Today Crinetics Pharmaceuticals News Today Zai Lab News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EOLS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recen...Brownstone Research | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
